Hickey, President and CEO of ReShape Lifesciences, the system has shown promise in reducing medication dependence for diabetics, potentially lowering treatment costs and the complications arising ...

Genetic profiling, targeted therapies reshape oncology care in the region ... and efficiency to the table Shutterstock Cancer treatment is leaving behind its rigid, conventional approach and ...

including laparoscopic bands and a novel diabetes treatment. The press release also contains customary forward-looking statements and outlines conditions related to the offering. ReShape ...

ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company has received a Notice of Allowance from the U.S.

Vagal Neuromodulation Provides Route to Treat Type 2 Diabetes and HypoglycemiaIRVINE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led ...

IRVINE, Calif., Feb. 15, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (“ReShape” or the “Company”) (Nasdaq: RSLS), the premier physician-led weight loss ...

ReShape Lifesciences (RSLS) announced that the Company has received a Notice of Allowance from the U.S. Patent and Trademark Office, USPTO, for ...

with the potential to treat Type 2 diabetes and hypoglycemia.” About The ReShape Diabetes Neuromodulation Device The ReShape Diabetes Neuromodulation system (formerly, Diabetes Bloc-Stim ...